Page last updated: 2024-08-23

bromocriptine and Cardiomyopathies

bromocriptine has been researched along with Cardiomyopathies in 50 studies

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.00)18.7374
1990's1 (2.00)18.2507
2000's9 (18.00)29.6817
2010's31 (62.00)24.3611
2020's8 (16.00)2.80

Authors

AuthorsStudies
Chaparro, S; Hernandez, GA; Ibrahim, M; Kittipibul, V; Mahabir, S; Saint Croix, GR; Trongtorsak, A1
Mujkanovic, J; Qayyum, AA1
Adamo, L; Al'Aref, SJ; Asnani, A; Chidambaram, V; Kumar, A; Lau, ES; Majella, MG; Mehta, JL; Ravi, R; Sharma, G; Sinha, S; Sivakumar, RK1
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Bauersachs, J; Berliner, D; König, T; Pfeffer, TJ1
Abdullaev, TA; Kurbanov, RD; Mirzarakhimova, ST; Tsoy, IA1
Demkow, M; Dzielinska, Z; Kryczka, KE1
Akhyari, P; Hilfiker-Kleiner, D; Horn, P; Kelm, M; Saeed, D; Westenfeld, R1
Arrigo, M; Blet, A; Mebazaa, A1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Fischer, D; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; Kühl, U; Michels, G; Pfister, R; Podewski, E; Schlitt, A; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R1
Coats, CJ; Dalzell, JR; Jackson, AM; Jhund, PS; Petrie, MC; Walker, NL1
Bauersachs, J; Berliner, D; Hallbaum, M; Hilfiker-Kleiner, D; König, T; Kühn, C; Napp, LC; Pfeffer, TJ; Schäfer, A; Schmitto, JD; Sieweke, JT; Tongers, J1
Bauersachs, J; Hilfiker-Kleiner, D; Sliwa, K2
Arany, Z; Ersbøll, AS; Gustafsson, F1
Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; König, T; Kühl, U; Michels, G; Moulig, VA; Pfeffer, T; Pfister, R; Podewski, E; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R; Zwadlo, C1
Fett, JD2
Afilalo, J; Avram, R; Bélisle, P; Bibas, L; Couture, E; Descarries, L; Desplantie, O; Diaz, A; Ducharme, A; Farand, P; Fortier, A; Harvey, L; Jolicoeur, EM; Ly, HQ; Malhamé, I; Marquis-Gravel, G; Pacheco, C; Poulin, A; Pranno, N; Rey, E; Sénéchal, M; Simard, F; Tournoux, F; Tran, D; Tremblay-Gravel, M1
A Kamiya, C; Eto, K; Fukui, D; Fukumoto, Y; Furusho, A; Kumanomido, J; Morikawa, N; Nakayoshi, T; Nishida, N; Nishihara, M; Watanabe, M; Yoshimura, H1
Bauersachs, J; Bovy, N; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Jordan, J; Labidi, S; Libhaber, E; Lichtinghagen, R; Podewski, E; Roentgen, P; Sliwa, K; Struman, I; Tsikas, D; von Kaisenberg, CS1
Hamada, T; Idei, M; Sumikura, H1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Podewski, E; Röntgen, P; Sonnenschein, K1
Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M1
Cardona-Guarache, R; Kron, J1
Lough, S1
Bouabdallaoui, N; Demondion, P; Ennezat, PV; Le Jemtel, TH; Lebreton, G; Mouquet, F1
Arany, Z; Elkayam, U1
Nicholls, M1
Dietz, R; Dudenhausen, JW; Elgeti, T; Habedank, D; Haverkamp, W; Kühnle, Y1
Emons, G; Hilfiker-Kleiner, D; Jahns, BG; Pieske, B; Stein, W1
Bretler, DM; Gislason, GH; Hansen, PR; Jørgensen, CH; Olesen, JB1
de Groote, P; Lamblin, N; Mouquet, F1
Biteker, M; Duran, NE; Ozkan, M1
Swalve-Bordeaux, S1
Becker, A; Blauwet, L; Hilfiker-Kleiner, D; Labidi, S; Libhaber, E; McMurray, J; Sliwa, K; Smedema, JP; Struhman, I; Struman, I; Tibazarwa, K; Yamac, H1
Elkayam, U; Goland, S1
Bultmann, I; Hilfiker-Kleiner, D; Sliwa, K; Yamac, H1
Abe, T; Akira, S; Amano, I; Nakai, A; Sawa, R; Takeshita, T1
Schröder, S; Strobel, J1
Czerski, T; Piotrowska-Kownacka, D1
Böhm, M; Friedrich, EB; Hilfiker-Kleiner, D; Kindermann, I; Labidi, S; Schirmer, SH; Schwarz, V; Sliwa, K; Solomayer, EF; Walenta, K1
Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S1
Hilfiker-Kleiner, D; Hoch, M; Podewski, E; Sliwa, K; Struman, I1
Holke, K; Schillinger, W; Schroeter, MR; Unsöld, B1
Leinwand, LA1
Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH1
Bertoni, PD; Canziani, R; Di Michele, R; Morandi, G1
Correia, J; Hopp, L; Iffy, L; O'Donnell, J1

Reviews

9 review(s) available for bromocriptine and Cardiomyopathies

ArticleYear
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
    Heart failure reviews, 2022, Volume: 27, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left

2022
Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
    Current problems in cardiology, 2023, Volume: 48, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Stroke Volume; Ventricular Function, Left

2023
Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
    Ginekologia polska, 2021, Volume: 92, Issue:2

    Topics: Adult; Bacterial Outer Membrane Proteins; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Health Knowledge, Attitudes, Practice; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome

2021
[Anesthetic management of parturients with peripartum cardiomyopathy].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:1

    Topics: Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Animals; Bromocriptine; Cardiomyopathies; Cesarean Section; Female; Heart Transplantation; Humans; Monitoring, Intraoperative; Mutation; Oxidative Stress; Perioperative Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin

2014
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
    The Canadian journal of cardiology, 2015, Volume: 31, Issue:12

    Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left

2015
Current knowledge and recent development on management of peripartum cardiomyopathy.
    European heart journal. Acute cardiovascular care, 2017, Volume: 6, Issue:4

    Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Incidence; Natriuretic Peptide, Brain; Oxidative Stress; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Radiography, Thoracic; Ventricular Dysfunction, Left

2017
Peripartum Cardiomyopathy.
    Circulation, 2016, Apr-05, Volume: 133, Issue:14

    Topics: Bromocriptine; Cardiomyopathies; Cardiovascular Agents; Disease Susceptibility; Female; Heart Failure; Heart Transplantation; Hormones; Humans; Hypertension; Incidence; Infant, Newborn; Lactation; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Multiple; Puerperal Disorders

2016
Prolactin: a new therapeutic target in peripartum cardiomyopathy.
    Heart (British Cardiac Society), 2010, Volume: 96, Issue:17

    Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Hormone Antagonists; Humans; Mice; Oxidative Stress; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

2010
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
    Current heart failure reports, 2012, Volume: 9, Issue:3

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Oxidative Stress; Peptide Fragments; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

2012

Trials

5 trial(s) available for bromocriptine and Cardiomyopathies

ArticleYear
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
    European heart journal, 2017, Sep-14, Volume: 38, Issue:35

    Topics: Adult; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Recovery of Function; Treatment Outcome; Ventricular Dysfunction, Left

2017
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2019, Volume: 108, Issue:3

    Topics: Bromocriptine; Cardiomyopathies; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hormone Antagonists; Humans; Magnetic Resonance Imaging, Cine; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right

2019
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2015, Volume: 104, Issue:11

    Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Humans; Multicenter Studies as Topic; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Research Design; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult

2015
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
    Circulation, 2010, Apr-06, Volume: 121, Issue:13

    Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Middle Aged; Parturition; Pilot Projects; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prolactin; Thromboembolism; Treatment Outcome; Ultrasonography; Ventricular Function, Left; Young Adult

2010
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
    Cell, 2007, Feb-09, Volume: 128, Issue:3

    Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor

2007

Other Studies

36 other study(ies) available for bromocriptine and Cardiomyopathies

ArticleYear
Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
    Current cardiology reviews, 2023, Volume: 19, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left

2023
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
[Peripartum Cardiomyopathy].
    Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:23

    Topics: Animals; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; Shock, Cardiogenic; Ventricular Dysfunction, Left

2022
[The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy].
    Kardiologiia, 2020, Jul-07, Volume: 60, Issue:6

    Topics: Bromocriptine; Cardiomyopathies; Humans; Peripartum Period; Quality of Life; Treatment Outcome

2020
Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy.
    ESC heart failure, 2017, Volume: 4, Issue:4

    Topics: Acute Disease; Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Heart-Assist Devices; Humans; Peripartum Period; Recovery of Function; Shock, Cardiogenic

2017
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
    European heart journal, 2017, 09-14, Volume: 38, Issue:35

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2017
Peripartum cardiomyopathy: diagnosis and management.
    Heart (British Cardiac Society), 2018, Volume: 104, Issue:9

    Topics: Anticoagulants; Bromocriptine; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotonic Agents; Contraception; Defibrillators; Delayed Diagnosis; Delivery, Obstetric; Drug Substitution; Female; Forecasting; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Peripartum Period; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Diagnosis; Puerperal Disorders; Recovery of Function; Risk Factors; Treatment Outcome

2018
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    European heart journal. Acute cardiovascular care, 2020, Volume: 9, Issue:2

    Topics: Adult; Bromocriptine; Cardiomyopathies; Combined Modality Therapy; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Shock, Cardiogenic; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left

2020
Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
    European heart journal, 2018, 10-01, Volume: 39, Issue:37

    Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders

2018
Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
    European heart journal, 2018, 10-01, Volume: 39, Issue:37

    Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders

2018
More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
    European heart journal, 2018, 11-14, Volume: 39, Issue:43

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2018
Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
    European heart journal, 2018, 11-14, Volume: 39, Issue:43

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders

2018
The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    ESC heart failure, 2019, Volume: 6, Issue:1

    Topics: Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Recovery of Function; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left

2019
The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation.
    Internal medicine (Tokyo, Japan), 2019, Feb-15, Volume: 58, Issue:4

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Middle Aged; Oocyte Donation; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2019
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Basic research in cardiology, 2013, Volume: 108, Issue:4

    Topics: Adult; Antihypertensive Agents; Bromocriptine; Cardiomyopathies; Cohort Studies; Disease Management; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Humans; Oxidative Stress; Peripartum Period; Phenotype; Pregnancy; Prospective Studies; Registries; Stroke Volume; Treatment Outcome

2013
Treatment of Peripartum Cardiomyopathy: A Call to Action.
    The Canadian journal of cardiology, 2015, Volume: 31, Issue:12

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pyridazines

2015
Resident-initiated research bucks tradition.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Aug-11, Volume: 187, Issue:11

    Topics: Biomedical Research; Bromocriptine; Canada; Cardiology; Cardiomyopathies; Financial Management; Humans; Internship and Residency; Needs Assessment; Pilot Projects; Research Support as Topic

2015
An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
    European heart journal, 2016, 11-21, Volume: 37, Issue:44

    Topics: Airports; Animals; Bromocriptine; Cardiomyopathies; Female; Humans; Mice; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2016
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
    European journal of heart failure, 2008, Volume: 10, Issue:11

    Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Magnetic Resonance Imaging; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Recovery of Function

2008
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
    American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4

    Topics: Adult; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; HELLP Syndrome; Hormone Antagonists; Humans; Myocardium; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin

2008
[Peripartum cardiomyopathy].
    Ugeskrift for laeger, 2009, Jan-05, Volume: 171, Issue:1-2

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors

2009
Indication for bromocriptine in peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
The role of bromocriptine in peripartum cardiomyopathy.
    American journal of obstetrics and gynecology, 2009, Volume: 201, Issue:2

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
Correspondence (letter to the editor): Case numbers are tiny.
    Deutsches Arzteblatt international, 2009, Volume: 106, Issue:11

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2009
Bromocriptine for the treatment of peripartum cardiomyopathy.
    Circulation, 2010, Apr-06, Volume: 121, Issue:13

    Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

2010
Recovery from peripartum cardiomyopathy in a Japanese woman after administration of bromocriptine as a new treatment option.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2010, Volume: 77, Issue:4

    Topics: Asian People; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Humans; Natriuretic Peptide, Brain; Pleural Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography, Thoracic; Time Factors; Ultrasonography

2010
[Postpartum cardiomyopathy].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Bisoprolol; Bromocriptine; Cardiomyopathies; Female; Heparin, Low-Molecular-Weight; Humans; Mineralocorticoid Receptor Antagonists; Postpartum Period; Radiography; Ramipril; Risk Factors; Spironolactone; Sulfonamides; Torsemide; Treatment Outcome

2011
[Pulmonary oedema--as first symptom of the postpartum cardiomyopathy. The role of cardiac MRI in diagnostic process].
    Kardiologia polska, 2011, Volume: 69, Issue:9

    Topics: Bromocriptine; Cardiomyopathies; Cesarean Section; Diagnosis, Differential; Eclampsia; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography; Young Adult

2011
Circulating microparticles as indicators of peripartum cardiomyopathy.
    European heart journal, 2012, Volume: 33, Issue:12

    Topics: Adult; Analysis of Variance; Biomarkers; Bromocriptine; Cardiomyopathies; Case-Control Studies; Cell-Derived Microparticles; Female; Flow Cytometry; Hormone Antagonists; Humans; Pregnancy; Puerperal Disorders

2012
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
    Nature, 2012, May-09, Volume: 485, Issue:7398

    Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2012
[Gender effect on cardiomyopathy].
    Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6

    Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome

2012
Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:2

    Topics: Adult; Anticoagulants; Blood Coagulation Tests; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Female; Heart-Assist Devices; Humans; Peripartum Period; Pregnancy; Puerperal Disorders; Thrombosis; Treatment Outcome; Ventricular Function, Left

2013
Molecular events underlying pregnancy-induced cardiomyopathy.
    Cell, 2007, Feb-09, Volume: 128, Issue:3

    Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor

2007
Caution in the use of bromocriptine in peripartum cardiomyopathy.
    Journal of the American College of Cardiology, 2008, May-27, Volume: 51, Issue:21

    Topics: Bromocriptine; Cardiomyopathies; Developing Countries; Female; Heart Failure; Hormone Antagonists; Humans; Prolactin; Puerperal Disorders

2008
[Acromegalic cardiomyopathy: an echocardiographic study].
    Giornale italiano di cardiologia, 1983, Volume: 13, Issue:3

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Humans; Hypophysectomy; Male; Middle Aged

1983
Severe cardiac dysrhythmia in patients using bromocriptine postpartum.
    American journal of therapeutics, 1998, Volume: 5, Issue:2

    Topics: Adult; Arrhythmias, Cardiac; Bromocriptine; Cardiomyopathies; Causality; Dopamine Agonists; Electrocardiography; Fatal Outcome; Female; Humans; Hypertension; Lactation; Long QT Syndrome; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders

1998